Clinical development success rates for investigational drugs
Top Cited Papers
- 9 January 2014
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 32 (1), 40-51
- https://doi.org/10.1038/nbt.2786
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 2012 FDA drug approvalsNature Reviews Drug Discovery, 2013
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009Clinical Pharmacology & Therapeutics, 2010
- A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug DevelopmentManagement Science, 2009
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliancesJournal of Health Economics, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- Success rates for new drugs entering clinical testing in the United StatesClinical Pharmacology & Therapeutics, 1995
- Success rates in the United States drug development systemClinical Pharmacology & Therapeutics, 1984